Literature DB >> 3023908

Purified polyoma virus medium T antigen has tyrosine-specific protein kinase activity but no significant phosphatidylinositol kinase activity.

W Koch, A Carbone, G Walter.   

Abstract

Medium T antigen, the transforming protein of polyoma virus, is associated with pp60c-src and strongly activates its tyrosine-specific protein kinase activity. We investigated whether the medium T-pp60c-src complex is also associated with an activity that phosphorylates the membrane phospholipid phosphatidylinositol, as shown for pp60v-src and p68v-ros, the transforming proteins of Rous sarcoma virus and avian sarcoma virus UR2, respectively. Medium T was purified by affinity chromatography from extracts of polyoma virus-infected mouse fibroblasts. It was bound to antibodies against a peptide corresponding to the carboxy terminus of medium T and released from the immune complex with an excess of the same peptide. In a second step, the partially purified medium T was bound to antibodies against another peptide corresponding to an internal region of medium T and released with excess peptide. Further purification was carried out with a monoclonal antibody against pp60c-src. Samples from each purification step were examined for protein kinase and phosphatidylinositol kinase activity. The highly purified preparations of the medium T-pp60c-src complex showed very low levels of phosphatidylinositol kinase activity, and no difference between medium T from transforming viruses and nontransforming hr-t mutants was detected. In contrast, protein kinase activity was associated with medium T purified from transforming viruses but not from hr-t mutants.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3023908      PMCID: PMC367724          DOI: 10.1128/mcb.6.6.1866-1874.1986

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  30 in total

1.  New classes of viable deletion mutants in the early region of polyoma virus.

Authors:  B E Griffin; C Maddock
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

2.  Phosphatidylinositol kinase activity in virus-transformed and nontransformed cells.

Authors:  S Sugano; H Hanafusa
Journal:  Mol Cell Biol       Date:  1985-09       Impact factor: 4.272

3.  Tumor antigens induced by nontransforming mutants of polyoma virus.

Authors:  J Silver; B Schaffhausen; T Benjamin
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

4.  Thin-layer chromatography of the phosphoinositides.

Authors:  F Gonzalez-Sastre; J Folch-Pi
Journal:  J Lipid Res       Date:  1968-07       Impact factor: 5.922

5.  DNA sequences of polyoma virus early deletion mutants.

Authors:  N Smolar; B E Griffin
Journal:  J Virol       Date:  1981-06       Impact factor: 5.103

6.  Evidence that the phosphorylation of tyrosine is essential for cellular transformation by Rous sarcoma virus.

Authors:  B M Sefton; T Hunter; K Beemon; W Eckhart
Journal:  Cell       Date:  1980-07       Impact factor: 41.582

7.  Identification of DNA sequence changes leading to loss of transforming ability in polyoma virus.

Authors:  G G Carmichael; T L Benjamin
Journal:  J Biol Chem       Date:  1980-01-10       Impact factor: 5.157

8.  Transforming gene product of Rous sarcoma virus phosphorylates tyrosine.

Authors:  T Hunter; B M Sefton
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

9.  Antibodies specific for the polyoma virus middle-size tumor antigen.

Authors:  G Walter; M A Hutchinson; T Hunter; W Eckhart
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

10.  Transformation of rat cells by an altered polyoma virus genome expressing only the middle-T protein.

Authors:  R Treisman; U Novak; J Favaloro; R Kamen
Journal:  Nature       Date:  1981-08-13       Impact factor: 49.962

View more
  17 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

2.  Characterization of the interaction of polyomavirus middle T antigen with type 2A protein phosphatase.

Authors:  E T Ulug; A J Cartwright; S A Courtneidge
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

3.  Interactions between polyomavirus medium T antigen and three cellular proteins of 88, 61, and 37 kilodaltons.

Authors:  T Grussenmeyer; A Carbone-Wiley; K H Scheidtmann; G Walter
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

4.  Evidence for two distinct phosphatidylinositol kinases in fibroblasts. Implications for cellular regulation.

Authors:  M Whitman; D Kaplan; T Roberts; L Cantley
Journal:  Biochem J       Date:  1987-10-01       Impact factor: 3.857

Review 5.  Protein phosphatases and DNA tumor viruses: transformation through the back door?

Authors:  M C Mumby; G Walter
Journal:  Cell Regul       Date:  1991-08

6.  Constant expression and activity of protein phosphatase 2A in synchronized cells.

Authors:  R Ruediger; J E Van Wart Hood; M Mumby; G Walter
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

7.  Association of protein phosphatase 2A with polyoma virus medium tumor antigen.

Authors:  G Walter; R Ruediger; C Slaughter; M Mumby
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

8.  Separation of PP2A core enzyme and holoenzyme with monoclonal antibodies against the regulatory A subunit: abundant expression of both forms in cells.

Authors:  E Kremmer; K Ohst; J Kiefer; N Brewis; G Walter
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

9.  Molecular cloning and sequence of cDNA encoding polyoma medium tumor antigen-associated 61-kDa protein.

Authors:  G Walter; F Ferre; O Espiritu; A Carbone-Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

10.  Novel monoclonal antibodies that differentiate between the binding of pp60c-src or protein phosphatase 2A by polyomavirus middle T antigen.

Authors:  S M Dilworth; V P Horner
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.